September 19, 2010 by Post Team 

Qr678, MUMBAI: A couple of doctors in Hyderabad, Debraj Shome and Kapoor Rinky, maintain that their homegrown invention, QR 678, could stop the most recalcitrant hairfall. Balding could be a thing of the past, says Dr. Kapoor, a dermatologist attached to the Apollo Hospital.

The couple said that his invention requires four years of research, the various stages of development in the laboratories of the Tata Memorial Hospital, IIT Mumbai and Hyderabad’s Apollo Hospital. “If there is no research on it yet,” says Dr Shome, “is because we have not patented the molecule, which is basically a mixture of many growth factors.”

Each pool of medical patients underwent 700-odd from five to eight shots at a price of Rs 5,000 each. Anaida Indipop singer is one of the celebrities Mumbai Charminar zips into town every three weeks for a shot. Hair care is big business in India. Plastic surgeon Dr. S Keswani says hair transplantation is the fastest growing sector, second only to liposuction, cosmetic surgery in India charts.

Dr. Satish Bhatia dermatologist, who practices out of his clinic cooperage European treatment started three months ago. “Stem cells are known to assume the role of skin, bone and muscle. Use stem cells derived from adipose tissue already know their role and grow into tumors,” he says. His drink is imported from Italy, at a cost of Rs 25,000. “If the patient wants it’s own stem cells derived from fat cells themselves, then the cost goes up four times,” he adds.

Dr. Bhatia believes the growth factors and stem cells are the closest things in the care of the hair. “People are tired of hair transplants, which have a bushy appearance and artificial appearance. One of 10 people complain transplant side effects such as inflammation and infection. So injections of stem cells that cause inflammation are local and redness of only 48 hours welcome, “he adds.

Report to Team

Please feel free to send if you have any questions regarding this post , you can contact on

Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.


Comments are closed.